LILRB2 and neoplasm: One of the epigenetically upregulated genes in these oropharyngeal tumors, the Leukocyte immunoglobulin-like receptor B2 (LILRB2), has been shown to be overexpressed and is a tumor promoting gene in HCC as well (Li et al., 2018).